Elicio Therapeutics Inc (ELTX)
7.88
+0.37
(+4.93%)
USD |
NASDAQ |
May 31, 16:00
7.90
+0.02
(+0.25%)
Pre-Market: 20:00
Elicio Therapeutics Accounts Payable (Quarterly): 1.105M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.105M |
December 31, 2023 | 4.369M |
September 30, 2023 | 4.406M |
Date | Value |
---|---|
June 30, 2023 | 4.265M |
December 31, 2022 | 2.805M |
March 31, 2021 | 2.429M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.105M
Minimum
Mar 2024
4.406M
Maximum
Sep 2023
3.230M
Average
3.535M
Median
Accounts Payable (Quarterly) Benchmarks
Immuneering Corp | 2.271M |
Outlook Therapeutics Inc | 4.363M |
Amylyx Pharmaceuticals Inc | 21.45M |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 3.443M |